Sinus Balloon Dilation System Market to Grow at 5.7% CAGR Through 2032
According to a newly published market research report by 24LifeSciences, global Sinus Balloon Dilation System market was valued at USD 52.6 million in 2024 and is projected to reach USD 77.1 million by 2031, growing at a compound annual growth rate (CAGR) of 5.7% during the forecast period 2025–2031.
The Sinus Balloon Dilation System is a medical device used to treat sinusitis or sinus blockage. The system employs a non-invasive treatment method that is widely used in the field of ENT (Ear, Nose, and Throat) to address chronic rhinosinusitis (CRS). CRS affects approximately 12.5% of the U.S. population, with over 30 million Americans diagnosed annually. The system works by introducing an uninflated balloon catheter into the affected sinus and then slowly inflating the balloon to dilate the sinus ostia and spaces associated with the paranasal sinus cavities, thereby restoring normal drainage and relieving symptoms.
Download a Free Sample Report (PDF): https://www.24lifesciences.com..../download-sample/547
